Evidence map›Paper›PMID 26703471›Full record

ArticleThe Journal of biological chemistry2016

Different Fatty Acids Compete with Arachidonic Acid for Binding to the Allosteric or Catalytic Subunits of Cyclooxygenases to Regulate Prostanoid Synthesis.

Liang Dong, Hechang Zou, Chong Yuan, Yu H Hong, Dmitry V Kuklev, William L Smith

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 76 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Allosteric regulation of prostaglandin endoperoxide HThe Journal of biological chemistry · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. "A Time to Tear Down and a Time to Mend": The Role of Eicosanoids in Atherosclerosis.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. The Biosynthesis of Enzymatically Oxidized Lipids.Frontiers in endocrinology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Liang DongFrom the Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109.
Hechang ZouFrom the Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109.
Chong YuanFrom the Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109.
Yu H HongFrom the Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109.
Dmitry V KuklevFrom the Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109.
William L SmithFrom the Department of Biological Chemistry, University of Michigan, Ann Arbor, Michigan 48109 smithww@umich.edu.
University of Michigan–Ann Arbor · US

Funding

Pilot Study: POPULATION PHARMACOLOGYU54HL117798 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2016
$18.5M
Translational Research in GI CancerP50CA130810 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BRENNER, DEAN E. · 2010 to 2016
$11.8M
Catalysis by Prostaglandin Endoperoxide H SynthasesR01GM068848 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SMITH, WILLIAM L · 2003 to 2014
$5.6M
NCI NIH HHS CA130810NCI NIH HHS P50 CA130810NHLBI NIH HHS HL117798NHLBI NIH HHS U54 HL117798NIGMS NIH HHS GM68848NIGMS NIH HHS R01 GM068848
6 · The paper itself

Abstract

Prostaglandin endoperoxide H synthases (PGHSs), also called cyclooxygenases (COXs), convert arachidonic acid (AA) to PGH2. PGHS-1 and PGHS-2 are conformational heterodimers, each composed of an (Eallo) and a catalytic (Ecat) monomer. Previous studies suggested that the binding to Eallo of saturated or monounsaturated fatty acids (FAs) that are not COX substrates differentially regulate PGHS-1 versus PGHS-2. Here, we substantiate and expand this concept to include polyunsaturated FAs known to modulate COX activities. Non-substrate FAs like palmitic acid bind Eallo of PGHSs stimulating human (hu) PGHS-2 but inhibiting huPGHS-1. We find the maximal effects of non-substrate FAs on both huPGHSs occurring at the same physiologically relevant FA/AA ratio of ∼20. This inverse allosteric regulation likely underlies the ability of PGHS-2 to operate at low AA concentrations, when PGHS-1 is effectively latent. Unlike FAs tested previously, we observe that C-22 FAs, including ω-3 fish oil FAs, have higher affinities for Ecat than Eallo subunits of PGHSs. Curiously, C-20 ω-3 eicosapentaenoate preferentially binds Ecat of huPGHS-1 but Eallo of huPGHS-2. PGE2 production decreases 50% when fish oil consumption produces tissue EPA/AA ratios of ≥0.2. However, 50% inhibition of huPGHS-1 itself is only seen with ω-3 FA/AA ratios of ≥5.0. This suggests that fish oil-enriched diets disfavor AA oxygenation by altering the composition of the FA pool in which PGHS-1 functions. The distinctive binding specificities of PGHS subunits permit different combinations of non-esterified FAs, which can be manipulated dietarily, to regulate AA binding to Eallo and/or Ecat thereby controlling COX activities.

Indexed as

Allosteric RegulationArachidonic AcidCyclooxygenase 1Cyclooxygenase 2HumansPalmitic AcidProstaglandin H2Protein BindingSubstrate SpecificityArachidonic AcidCyclooxygenase 1Cyclooxygenase 2Palmitic AcidProstaglandin H2PTGS1 protein, humanPTGS2 protein, humanallosteric regulationcyclooxygenase (COX)docosahexaenoic acideicosanoideicosapentaenoic acidfatty acidhalf-sitespalmitic acidprostaglandinω-3 fatty acid

Identifiers

PMID26703471
PMCPMC4759183
OpenAlexW2216643141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.